News Center

Discover all of the trending news of the Ipsen Group


12 results

People

Ipsen France signs milestone Cancer and Employment Charter at French Cancer National Institute

On Friday, 23rd November, Ipsen France celebrated a significant milestone by signing the Cancer & Employment Charter…

Group

Ipsen Group inaugurates new office in Singapore

Ipsen, a leading  biopharmaceutical group  dedicated to improving lives through innovative medicines in specialty care (oncology , neuroscience and rare diseases) and…

Oncology

How Ipsen is waging war on cancer by Bartek BEDNARZ

10/18/2018 By Bartek BEDNARZ, Senior Vice-President, Oncology Franchise In the past 12 months we are…

Oncology

Spread the word: it is Liver Cancer Awareness Month

October is Liver Cancer Awareness Month, a global initiative that aims to raise understanding of…

Innovation

Ipsen joins Biotechnology Innovation Organization (BIO) To Advance Growth and Innovation

Ipsen is delighted to join the Biotechnology Innovation Organization (BIO), the largest association of…

Group

Ipsen appoints Dr. Yan Moore as Senior Vice President, Head of Oncology Therapeutic Area; and Dr. Alexander McEwan, FRCPC, as Vice President, Head of Radiopharmaceuticals

September 28, 2018

Paris (France), 27 September 2018 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointments of Dr.…

Group

Ipsen relocating German affiliate to Munich

September 21, 2018

Ipsen Pharma GmbH, the German subsidiary of the global specialty-driven biopharmaceutical group Ipsen, has been…

Event

Boston and Paris – two rich ecosystems of R&D excellence

Sunday 3rd June Today I’m giving the keynote speech at the second Boston-Paris Biotechnology Summit – this year…

Event Oncology

IPSEN SPONSORS THE STROKE ACTION PLAN FOR EUROPE (2018-2030)

On May 23rd, the Stroke Alliance for Europe (SAFE) and the European Stroke Organization (ESO)…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020